Multiple Sclerosis
Conference Coverage
Fingolimod switch from an injectable linked to improved outcomes in relapsing MS
SAN DIEGO – The benefit of the switch was observed regardless of previous treatment status.
Conference Coverage
Extended-interval dosing of natalizumab linked to lower risk of PML
SAN DIEGO – Dangerous viral brain disease is more likely to strike at-risk MS patients who rely on standard-interval dosing.
Conference Coverage
Is MS caused by one-two punch of pinworm and Epstein-Barr virus?
SAN DIEGO – New theory suggests a double hit of infections could prime people to develop the disease.
Conference Coverage
Do Neurologists Adequately Screen Patients With MS for Cognitive Impairment and Depression?
SAN DIEGO—Current practice related to screening patients with multiple sclerosis (MS) for cognitive impairment and depression may need improvement...
Conference Coverage
Study identifies characteristics that may constitute the MS prodrome
SAN DIEGO - Some neurologic health problems may be early signs of multiple sclerosis
Conference Coverage
Physicians often bypass cognition, depression screening in MS
SAN DIEGO - Physicians who did perform screening hardly ever used validated tools.
Conference Coverage
Nearly half of MS patients treated by primary docs miss out on meds
SAN DIEGO – Patients at specialty centers are much more likely to receive disease-modifying therapies despite having fewer symptoms.
Conference Coverage
VIDEO: Teriflunomide and dimethyl fumarate are comparable in relapsing-remitting MS
SAN DIEGO – Small study of oral drugs finds they’re similar in terms of efficacy and adverse effects, and both can be used “with equal confidence...
Video
Adil Harroud, MD
At the ACTRIMS 2018 Forum, Dr. Harroud describes his investigation of the potential link between age at puberty onset and risk of MS....
Conference Coverage
VIDEO: Advanced practice providers take on many roles in MS care
SAN DIEGO – Survey finds most MS advanced practice providers are highly satisfied with their jobs, patients, and colleagues.
Conference Coverage
‘Real-world evidence’ used to compare agents for relapsing-remitting MS
SAN DIEGO – The comparative effectiveness of delayed-release dimethyl fumarate was analyzed against fingolimod and glatiramer acetate.